Beranda › Mieloma Multipel › Kentucky › Louisville
Uji klinis Mieloma Multipel di Louisville, KY
12 studi untuk Mieloma Multipel mencari peserta di lokasi sekitar Louisville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Menerima pesertaFase 3
- Research Site, Louisville
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 3
- Norton Cancer Institute, Louisville
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 3
- Norton Cancer Institute, Louisville
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 2
- Norton Cancer Institute, Louisville
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Menerima pesertaFase 3
- Norton Cancer Institute, Louisville
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Menerima pesertaFase 1/2
- Norton Healthcare, Inc., Louisville
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 2
- Norton Women's and Children's Hospital, Louisville
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Menerima pesertaFase 3
- Research Site, Louisville
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Menerima pesertaFase 1
- Norton Cancer Institute St. Matthews, Louisville
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Menerima pesertaFase 1/2
- Norton Cancer Institute, Louisville
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1/2
- Norton Cancer Institute, Louisville
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Baptist Floyd, New Albany · 4 mi jauhnya
Uji klinis Mieloma Multipel di kota lain
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA42 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- St. Louis, MO24 studi
- Rochester, MN24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Chicago, IL22 studi
Studi lain di Louisville
- Kanker Paru Non-Sel Kecil22 studi
- Obesitas17 studi
- Kelebihan Berat Badan15 studi
- Kanker (semua jenis)14 studi
- Gagal Jantung13 studi
- Leukemia Mieloid Akut12 studi
- Kanker Ovarium12 studi
- Kanker Payudara11 studi
- Karsinoma Sel Skuamosa Kepala dan Leher11 studi
- Kanker Paru11 studi
- Melanoma10 studi
- Kanker Prostat10 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.